ARG1 and neoplasm: In primary tumor sites, suppressive myeloid cells recruited by cancer cells play an important role in inhibiting anti-tumor immune responses using many mechanisms extensively reviewed elsewhere (expression of ARG1, production of NO, ROS, and prostaglandin E2) (50, 51).